![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Background. Cardiac involvement in light-chain amyloidosis (AL) frequently results in heart failure with dyspnoea. In heart failure due to ischemic or idiopathic etiology, respiratory muscle dysfunction and ventilatory inefficiency contribute to symptoms and are independent prognostic predictors. However, in patients with AL, respiratory muscle function has not been elucidated.
Methods. In 46 consecutive male patients with AL, lung function, maximal inspiratory (Pimax) and expiratory (Pemax) mouth occlusion pressures, cardiopulmonary exercise testing, echocardiography, and cardiac biomarkers were prospectively studied.
Results. Pimax and Pemax were reduced, P0.1 did not differ between controls and AL. Pimax and Pemax were reduced in AL with congestive heart failure compared with asymptomatic patients (median (range) 5.4 (2.3–12.4) kPa vs 10.4 (6.5–14.0) kPa; p < 0.05). Respiratory muscle weakness occurred in systolic and diastolic LV dysfunction. Pimax was associated with peak exercise oxygen uptake, respiratory inefficiency, wall thickness, and N-terminal pro-brain natriuretic peptide.
Conclusions. Respiratory muscle dysfunction and ventilatory inefficiency correlates well with intraventricular septum thickness and peak oxygen uptake and are present even in patients with diastolic dysfunction. Respiratory muscle dysfunction might contribute to dyspnea and exercise limitation and appears to represent a marker of cardiac impairment even in diastolic heart failure. Further studies of Pimax as a potential non-invasive prognostic marker are needed.
| Abbreviations | ||
| AL | = | light-chain amyloidosis |
| CHF | = | congestive heart failure |
| DHF | = | diastolic heart failure |
| FEV1 | = | forced expiratory volume in 1 s |
| NHF | = | no heart failure |
| Pemax | = | maximal expiratory mouth occlusion pressure |
| Pimax | = | maximal inspiratory mouth occlusion pressure |
| Rtot | = | total airway resistance |
| SHF | = | systolic heart failure |
| VC | = | vital capacity |
| VCO2 | = | carbon dioxide production |
| VE | = | minute ventilation |
| Abbreviations | ||
| AL | = | light-chain amyloidosis |
| CHF | = | congestive heart failure |
| DHF | = | diastolic heart failure |
| FEV1 | = | forced expiratory volume in 1 s |
| NHF | = | no heart failure |
| Pemax | = | maximal expiratory mouth occlusion pressure |
| Pimax | = | maximal inspiratory mouth occlusion pressure |
| Rtot | = | total airway resistance |
| SHF | = | systolic heart failure |
| VC | = | vital capacity |
| VCO2 | = | carbon dioxide production |
| VE | = | minute ventilation |